Table: Rohto -Q1 group results

Rohto Pharmaceutical

10/08/2021 07:00

Aug 10 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               42.32               38.64           182.00    
                                       (-7.8 pct)       (+0.4 pct)  
  Operating            6.01                3.58            23.10    
                                       (-7.4 pct)       (+0.5 pct)  
  Recurring            6.52                3.80            23.90    
                                       (-3.1 pct)       (+0.0 pct)  
  Net                  4.73                1.75            17.10    
                                       (-21.2 pct)      (+2.1 pct)  
  EPS               41.48 yen           15.32 yen       149.91 yen  
  EPS Diluted       41.36 yen           15.27 yen                   
  Ann Div                               28.00 yen        30.00 yen  
  -Q2 div                               13.00 yen        15.00 yen  
  -Q4 div                               15.00 yen        15.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T